Compare Immunovant Inc. Common Stock (IMVT) vs United Airlines Holdings Inc (UAL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs United Airlines Holdings Inc — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while United Airlines Holdings Inc trades at $108.53 (market cap $35.76B). The key difference: United Airlines Holdings Inc is far larger — about 5.4× Immunovant Inc. Common Stock's market cap, and United Airlines Holdings Inc is more actively traded (5,327,551 versus 1,131,364). Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and United Airlines Holdings Inc for 46 Days on average.
| IMVT | UAL | |
|---|---|---|
Market Cap | $6.62B | $35.76B |
Volume | 1,131,364 | 5,327,551 |
Sector | Health | Industrials |
52-Week High | $44.96 | $136.11 |
52-Week Low | $17.03 | $85.21 |
Typical Hold Time | 0 Days | 46 Days |
Enterprise Value | $5.72B | $52.79B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
United Airlines (UAL) trades at $110.17, down 1.53% on the day, with a bearish technical signal from moving averages. The stock shows strong fundamentals with a low P/E of 10.32 and consistent earnings beats, including Q2 2026 EPS of $1.99 versus $1.88 expected. Revenue growth has climbed from $45.0B in 2022 to $59.1B in 2025, with net income margin improving to 5.67%. Recent news highlights aggressive customer acquisition efforts targeting Delta's premium flyers.
The outlook is mixed: analyst consensus is strongly bullish with a $158.10 price target and no sell ratings, but technical indicators and rising fuel costs pose near-term risks. Earnings sustainability and market share gains from competitor targeting present upside, while debt levels and operational volatility remain challenges for shareholder value.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About United Airlines Holdings Inc
United Airlines is a major U.S. network carrier. United's hubs include San Francisco, Chicago, Houston, Denver, Los Angeles, New York/Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international travel than legacy peers.
Read more on UAL →
